Quoin Pharmaceuticals, Ltd. American Depositary Shares

QNRXNASDAQ • USD
4.53 USD
↘ 0.19 (4.00%)🟢LIVE (AS OF 03:42 PM EDT)
🟢Market: OPEN

QNRX is currently priced at $4.53. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 1, 2026.

Open?$4.81
High?$5.20
Low?$4.53
Prev. Close?$4.72
Volume?13.3K
Avg. Volume?1.1M
VWAP?$4.65
Rel. Volume?0.01x
Bid / Ask
Bid?$3.91 × 100
Ask?$5.25 × 100
Spread?$1.34
Midpoint?$4.58
Valuation & Ratios
Market Cap?9.5M
Shares Out?2.0M
P/E Ratio?N/A
P/B Ratio?2.41
EPS?-$9.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
9.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.58Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?126.3K
Days to Cover?1.0
Avg Daily Volume152.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.76Adequate
Quick Ratio?1.76Adequate
Cash Ratio?0.58Adequate
Debt/Equity?0.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
66
2.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-474.6%WEAK▾
ROA?
S&P
3
-155.9%WEAK▾
Cash Flow & Enterprise
FCF?$-15273747
Enterprise Value?$6.8M
Fundamentals ratios updated end of day